Introduction
============

It is controversial whether all critically ill patients with RIFLE-F class acute kidney injury (AKI) should receive renal replacement therapy (RRT). We reviewed the outcome of open-heart surgery patients with severe AKI who did not receive RRT.

Methods
=======

We identified all patients who developed AKI after cardiac surgery during a 4-year period, and obtained baseline characteristics, intraoperative details and in-hospital outcomes. We analyzed physiological and biochemical features at the time of RRT initiation or at peak creatinine if no RRT was provided.

Results
=======

We reviewed 1,504 patients. Of these, 137 (9.1%) developed postoperative AKI with 71 meeting RIFLE-F criteria and 23 (32.4% of RIFLE-F cases) not receiving RRT. Compared with RRT-treated RIFLE-F patients, no-RRT patients had lower APACHE III scores, less intraaortic balloon pump requirements, shorter intensive care stay and a trend toward lower mortality. At peak creatinine, their urinary output, arterial pH and PaO~2~/FIO~2~ratio were all significantly higher. Their serum creatinine was also higher (304 vs. 262 μmol/l, *P*= 0.02). Only three died in-hospital. Detailed review of cause and mode of death was consistent with non-RRT-preventable deaths. In contrast, 27 patients with RIFLE-R or RIFLE-I class received RRT. Compared with RRT-treated RIFLE-F patients, they had a trend towards a more severe presentation and a higher mortality (51.8% vs. 29.2%, *P*= 0.02). See Figure [1](#F1){ref-type="fig"}.
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Conclusion
==========

After cardiac surgery, RRT is typically applied to patients with the most severe clinical presentation irrespective of creatinine levels. A RIFLE score-based trigger for RRT is unlikely to improve patient survival.
